You are currently viewing Public Meeting on Patient Focused Drug Development for Lung Cancer Part 1

Public Meeting on Patient Focused Drug Development for Lung Cancer Part 1



On June 28, 2013, FDA hosted a public meeting on Patient-Focused Drug Development for Lung Cancer. FDA was interested in obtaining patient perspectives on the impact of Lung Cancer on daily life and patient views on treatment approaches. For more information, visit

source

Leave a Reply